Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial
安罗替尼联合信迪利单抗一线治疗晚期结直肠癌患者（APICAL-CRC）：一项开放标签、单臂、II期试验
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02383-9
Wang, Zhan; Qin, Bao-Dong; Ye, Chen-Yang; Wang, Miao-Miao; Yuan, Ling-Yan; Yao, Hou-Shan; Jiao, Xiao-Dong; Liu, Ke; Zhou, Wen-Li; Qin, Wen-Xing; Sun, Li; Dai, Wei-Ping; Ling, Yan; Wu, Ying; Chen, Shi-Qi; Zhang, Ying-Fu; Shi, Dong-Min; Duan, Xiao-Peng; Zhong, Xue; He, Xi; Zhai, Wen-Xin; Zhang, Bei; Zhang, Da-Dong; Gao, Ning; Zang, Yuan-Sheng
